Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Felicetta Simeone is active.

Publication


Featured researches published by Felicetta Simeone.


The FASEB Journal | 2004

Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs

Marialuisa Lavitrano; Ryszard T. Smolenski; Antonino Musumeci; Massimo Maccherini; Ewa M. Slominska; Ernesto Di Florio; Adele Bracco; Antonio Mancini; Giorgio Stassi; Mariella Patti; Roberto Giovannoni; Alberto Froio; Felicetta Simeone; Monica Forni; Maria Laura Bacci; Giuseppe D’Alise; Emanuele Cozzi; Leo E. Otterbein; Magdi H. Yacoub; Fritz H. Bach; Fulvio Calise

Ischemia‐reperfusion injury, a clinical problem during cardiac surgery, involves worsened adenosine trisphosphate (ATP) generation and damage to the heart. We studied carbon monoxide (CO) pretreatment, proven valuable in rodents but not previously tested in large animals, for its effects on pig hearts subjected to cardiopulmonary bypass with cardioplegic arrest. Hearts of CO‐treated pigs showed significantly higher ATP and phosphocreatine levels, less interstitial edema, and apoptosis of cardiomyocytes and required fewer defibrillations after bypass. We conclude that treatment with CO improves the energy status, prevents edema formation and apoptosis, and facilitates recovery in a clinically relevant model of cardiopulmonary bypass surgery.


Biomedicine & Pharmacotherapy | 2002

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

Filippo Carlucci; Antonella Tabucchi; Bonizella Biagioli; Felicetta Simeone; Sabino Scolletta; F. Rosi; Enrico Marinello

Myocardial and endothelial damage is still a widely debated problem during the ischemia-reperfusion sequence in heart surgery. We evaluated myocardial purine metabolites, antioxidant defense mechanisms, oxidative status and endothelial dysfunction markers in 14 patients undergoing coronary artery by-pass graft (CABG). Heart biopsies were taken before aortic cross-clamping (t1), before clamp removal (t2) and 30 min after reperfusion (t3); perchloric extracts of the tissue were analyzed for glutathione, NAD, nucleotide nucleoside and base content by capillary electrophoresis (CE). In plasma samples from the coronary sinus we evaluated: nitrate and nitrite concentrations by CE, plasma glutathione peroxidase (plGPx) by ELISA, endothelin-1 (ET-1) by RIA and reactive oxygen metabolites (ROM) by colorimetric assay. During the ischemic period (t2) we observed a reduction in cellular NAD and GSH levels, as well as nitrate, nitrite and plGPx. ATP and GTP levels decreased and their catabolic products AMP, GMP, IMP, adenosine, inosine and hypoxanthine accumulated. The energy charge, ATP/ADP ratio, and nucleotide/(nucleoside + base) ratios decreased. At t3, levels of plasma ET-1 increased and monophosphate nucleotides tended to return to basal values. The energy charge did not increase but the nucleotide/(nucleoside + nucleobase) ratio recovered to some extent. Levels of nitrates plus nitrites continued to decrease. No significant variation in ROM levels was observed. Our data indicate that oxidative stress and endothelial damage are major events during CABG, overwhelming the scavenging capacity of the myocyte and preventing restoration of the normal energy balance for 30 min after reperfusion. The AMP deaminase pathway leading to IMP production is active during ischemia and adenosine is not the main compound derived from ATP break-down in the human heart. The possible role of extracorporeal circulation is also discussed.


BMC Medical Informatics and Decision Making | 2011

A simple clinical model for planning transfusion quantities in heart surgery.

Felicetta Simeone; Federico Franchi; Gabriele Cevenini; Antonino G.M. Marullo; Vittorio Fossombroni; Sabino Scolletta; Bonizella Biagioli; Pierpaolo Giomarelli; Paolo Barbini

BackgroundPatients undergoing heart surgery continue to be the largest demand on blood transfusions. The need for transfusion is based on the risk of complications due to poor cell oxygenation, however large transfusions are associated with increased morbidity and risk of mortality in heart surgery patients. The aim of this study was to identify preoperative and intraoperative risk factors for transfusion and create a reliable model for planning transfusion quantities in heart surgery procedures.MethodsWe performed an observational study on 3315 consecutive patients who underwent cardiac surgery between January 2000 and December 2007. To estimate the number of packs of red blood cells (PRBC) transfused during heart surgery, we developed a multivariate regression model with discrete coefficients by selecting dummy variables as regressors in a stepwise manner. Model performance was assessed statistically by splitting cases into training and testing sets of the same size, and clinically by investigating the clinical course details of about one quarter of the patients in whom the difference between model estimates and actual number of PRBC transfused was higher than the root mean squared error.ResultsTen preoperative and intraoperative dichotomous variables were entered in the model. Approximating the regression coefficients to the nearest half unit, each dummy regressor equal to one gave a number of half PRBC. The model assigned 4 units for kidney failure requiring preoperative dialysis, 2.5 units for cardiogenic shock, 2 units for minimum hematocrit at cardiopulmonary bypass less than or equal to 20%, 1.5 units for emergency operation, 1 unit for preoperative hematocrit less than or equal to 40%, cardiopulmonary bypass time greater than 130 minutes and type of surgery different from isolated artery bypass grafting, and 0.5 units for urgent operation, age over 70 years and systemic arterial hypertension.ConclusionsThe regression model proved reliable for quantitative planning of number of PRBC in patients undergoing heart surgery. Besides enabling more rational resource allocation of costly blood-conservation strategies and blood bank resources, the results indicated a strong association between some essential postoperative variables and differences between the model estimate and the actual number of packs transfused.


Archive | 1998

Myocardial Ischemic Injury During Cardio-Pulmonary by-Pass

Filippo Carlucci; Antonella Tabucchi; Bonizella Biagioli; Massimo Maccherini; Guido Sani; Felicetta Simeone; David Perrett; Enrico Marinello

Prolonged in vivo and ex vivo myocardial protection is one of the primary factors for the success of the procedure in the therapy of patients with end-stage cardiac disfunction. Advances in myocardial preservation for routine heart surgery and transplantation have been closely linked. Future advances in the understanding of myocardial energy metabolism and the limitation of oxygen-derived free radical induced injury will have wide application in both fields.


Cardiovascular Research | 2007

Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs

Ryszard T. Smolenski; Monica Forni; Massimo Maccherini; Maria Laura Bacci; Ewa M. Slominska; Hongjun Wang; PierMaria Fornasari; Roberto Giovannoni; Felicetta Simeone; Augusta Zannoni; Giacomo Frati; Ken Suzuki; Magdi H. Yacoub; Marialuisa Lavitrano


Transplantation Proceedings | 2001

Sexual disorders after heart transplantation.

A Basile; Massimo Maccherini; Francesco Diciolla; A Balistreri; D Bouklas; Gianfranco Lisi; T Toscano; Sergio Mondillo; Bonizella Biagioli; Felicetta Simeone; U. Papalia


Clinical Biochemistry | 1998

Myocardial ischemic injury and purine metabolism in patients undergoing coronary artery bypass.

Filippo Carlucci; Bonizella Biagioli; Massimo Maccherini; Guido Sani; Felicetta Simeone; Federico Bizzarri; David Perrett; Enrico Marinello; Roberto Pagani; Antonella Tabucchi


Transplantation Proceedings | 2003

Graft functional recovery and outcome after heart transplant: is troponin I a reliable marker?

Bonizella Biagioli; Felicetta Simeone; Luca Marchetti; Pierpaolo Giomarelli; Massimo Maccherini; Sabino Scolletta


ESICM | 2005

The quality of life after prolonged ICU stay.

E Maglioni; Sabino Scolletta; Luca Marchetti; Federico Franchi; R Signorini; Felicetta Simeone; Pierpaolo Giomarelli; Bonizella Biagioli


Clinical Biochemistry | 1997

Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis

Filippo Carlucci; Antonella Tabucchi; Bonizella Biagioli; Massimo Maccherini; Guido Sani; Felicetta Simeone; David Perrett; Enrico Marinello

Collaboration


Dive into the Felicetta Simeone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Guido Sani

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Perrett

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge